Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 8, 2001
Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes
B Ríhová, T Etrych, M Pechar, et al.
Folia Microbiologica
|
April 22, 2009
Expression of IGF-1R and iNOS in nasal polyps; epithelial cell homeostasis and innate immune mechanisms in pathogenesis of nasal polyposis
P Fundová, T Filipovský, D P Funda, et al.
Bioorganic & Medicinal Chemistry
|
March 1, 1996
New mimics of the acetate function in pheromone-based attraction
M Hoskovec, O Hovorka, B Kalinová, et al.
Bioconjugate Chemistry
|
September 20, 2000
Antiproliferative effect of a lectin- and anti-Thy-1.2 antibody-targeted HPMA copolymer-bound doxorubicin on primary and metastatic human colorectal carcinoma and on human colorectal carcinoma transfected with the mouse Thy-1.2 gene
B Ríhová, M Jelínková, J Strohalm, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 21, 2000
Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anti-cancer activity of antibody or (Fab')(2)-targeted conjugates and combined therapy with immunomodulators
B Ríhová, M Jelínková, J Strohalm, et al.
Scandinavian Journal of Immunology
|
June 15, 2005
Induction of systemic antitumour resistance with targeted polymers
B Rihova, J Strohalm, M Kovar, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 8, 2008
Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: in vitro effect of extra drug-free GlyPheLeuGly sequences
B Ríhová, J Strohalm, O Hovorka, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 5, 2002
Acquired and specific immunological mechanisms co-responsible for efficacy of polymer-bound drugs
B Ríhová, J Strohalm, K Kubácková, et al.
Food Additives and Contaminants
|
September 22, 2001
Biological activities of oligoketide pigments of Monascus purpureus
L Martínková, P Patáková-Jůzlová, V Krent, et al.
Nature Communications
|
May 31, 2022
History-dependent domain and skyrmion formation in 2D van der Waals magnet Fe<sub>3</sub>GeTe<sub>2</sub>
M T Birch, L Powalla, S Wintz, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 8, 2001
Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes
B Ríhová, T Etrych, M Pechar, et al.
Folia Microbiologica
|
April 22, 2009
Expression of IGF-1R and iNOS in nasal polyps; epithelial cell homeostasis and innate immune mechanisms in pathogenesis of nasal polyposis
P Fundová, T Filipovský, D P Funda, et al.
Bioorganic & Medicinal Chemistry
|
March 1, 1996
New mimics of the acetate function in pheromone-based attraction
M Hoskovec, O Hovorka, B Kalinová, et al.
Bioconjugate Chemistry
|
September 20, 2000
Antiproliferative effect of a lectin- and anti-Thy-1.2 antibody-targeted HPMA copolymer-bound doxorubicin on primary and metastatic human colorectal carcinoma and on human colorectal carcinoma transfected with the mouse Thy-1.2 gene
B Ríhová, M Jelínková, J Strohalm, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 21, 2000
Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anti-cancer activity of antibody or (Fab')(2)-targeted conjugates and combined therapy with immunomodulators
B Ríhová, M Jelínková, J Strohalm, et al.
Scandinavian Journal of Immunology
|
June 15, 2005
Induction of systemic antitumour resistance with targeted polymers
B Rihova, J Strohalm, M Kovar, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 8, 2008
Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: in vitro effect of extra drug-free GlyPheLeuGly sequences
B Ríhová, J Strohalm, O Hovorka, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 5, 2002
Acquired and specific immunological mechanisms co-responsible for efficacy of polymer-bound drugs
B Ríhová, J Strohalm, K Kubácková, et al.
Food Additives and Contaminants
|
September 22, 2001
Biological activities of oligoketide pigments of Monascus purpureus
L Martínková, P Patáková-Jůzlová, V Krent, et al.
Nature Communications
|
May 31, 2022
History-dependent domain and skyrmion formation in 2D van der Waals magnet Fe<sub>3</sub>GeTe<sub>2</sub>
M T Birch, L Powalla, S Wintz, et al.
Page
of 3